Sanofi Posts More Positive Olipudase Alfa Data As Approval Decisions Loom

First Potential Therapy For Rare Lysosomal Storage Disease

Paperwork
Sanofi amasses more data on olipudase alfa • Source: Alamy

More from Rare Diseases

More from Scrip